We use cookies to personalize content and to analyze our traffic. Please decide if you are willing to accept cookies from our website.

ORI Capital

As a healthcare fund, we hope to be both financially successful and socially impactful

Our Team

Founder & Senior Partner

Simone Song


Dicky To


Elaine Yang

Senior Associate

James Huang

Research Analyst

Otto Cheung

Research Analyst

Sarah Mak

Research Analyst

Evangeline Kang

Research Analyst

Daniel Zhang

Assistant to Founding Partner

Wendy Wang

Financial Controller

Cathy Choi

In-house Counsel

Edward Tung

HR & Office Manager

Gillian Zhou

Our Portfolio


Read More
The only company to date that can apply stem cell therapy to cure type 1 diabetes
Read More
World’s first fully humanized antibodies selection platform generating disease-modifying drugs


Read More
World’s leading gene therapy company targeting multiple diseases with limited or no existing treatment

The first ever high-volume biologic injector

The only company to date that can deliver drugs to pancreatic tumors using its innovative delivery device

First IVD company in tumor testing space making precision medicine the first-line treatment

The leading oncolytic virus company in Phase 3 bladder cancer

Developing CAR-T therapy focusing on brand new target for solid tumor

The world’s first cloud-based platform for AI medical imaging analysis

Cutting edge anti-aging nutraceutical company